×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
西安交通大学 [3]
湖南中医药大学 [1]
中国医学科学院 北京... [1]
内容类型
期刊论文 [5]
发表日期
2016 [5]
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共5条,第1-5条
帮助
限定条件
发表日期:2016
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Rosiglitazone attenuates angiotensin II-induced C-reactive protein expression in hepatocytes via inhibiting AT(1)/ROS/MAPK signal pathway
期刊论文
INTERNATIONAL IMMUNOPHARMACOLOGY, 2016, 卷号: 31, 期号: [db:dc_citation_issue], 页码: 178-185
作者:
Zhao, Jingjing
;
Liu, Juntian
;
Pang, Xiaoming
;
Zhang, Xiaolu
;
Wang, Shuyue
收藏
  |  
浏览/下载:3/0
  |  
提交时间:2019/12/02
Angiotensin II
C-reactive protein
Rosiglitazone
Inflammation
Hepatocytes
Epigallocatechin-3-gallate inhibits angiotensin II-induced C-reactive protein generation through interfering with the AT(1)-ROS-ERK1/2 signaling pathway in hepatocytes
期刊论文
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2016, 卷号: 389, 期号: [db:dc_citation_issue], 页码: 1225-1234
作者:
Zhao, Jingjing
;
Liu, Juntian
;
Pang, Xiaoming
;
Zhang, Xiaolu
;
Wang, Shuyue
收藏
  |  
浏览/下载:4/0
  |  
提交时间:2019/12/02
EGCG
Angiotensin II
C-reactive protein
Hepatocytes
Inflammation
Epigallocatechin-3-gallate inhibits angiotensin II-induced C-reactive protein generation through interfering with the AT1-ROS-ERK1/2 signaling pathway in hepatocytes.
期刊论文
Naunyn-Schmiedeberg's archives of pharmacology, 2016, 卷号: 389, 页码: 1225-1234
作者:
Zhao Jingjing
;
Liu Juntian
;
Pang Xiaoming
;
Zhang Xiaolu
;
Wang Shuyue
收藏
  |  
浏览/下载:5/0
  |  
提交时间:2019/11/26
C-reactive protein
Angiotensin II
EGCG
Hepatocytes
Inflammation
The anti-dementia drug candidate, (-)-clausenamide, improves memory impairment through its multi-target effect
期刊论文
2016, 卷号: 162, 页码: 179-187
作者:
Chu, Shifeng
;
Liu, Shaolin
;
Duan, Wenzhen
;
Cheng, Yong
;
Jiang, Xueying
收藏
  |  
浏览/下载:2/0
  |  
提交时间:2020/01/04
Chirality
Clausenamide
Dementia
Long-term potentiation
Signaling pathway
Calcium
The anti-dementia drug candidate, (-)-clausenamide, improves memory impairment through its multi-target effect
期刊论文
Pharmacology and Therapeutics, 2016, 卷号: 162, 页码: 179-187
作者:
Chu, Shifeng
;
Liu, Shaolin
;
Duan, Wenzhen
;
Cheng, Yong
;
Jiang, Xueying
收藏
  |  
浏览/下载:8/0
  |  
提交时间:2019/12/27
Chirality
Clausenamide
Dementia
Long-term potentiation
Signaling pathway
Calcium
6-OHDA
6-hydroxyldopamine
ACE
acetylcholinesterase
ACh
acetylcholine
AD
Alzheimer's disease
AUC0–12 h
0–12 h area under curve
APP
amyloid precursor protein
APV
R-2-amino-5-phosphonopentanoate
AUC0−∝
whole area under curve
BBB
blood–brain barrier
BDNF
brain-derived neurotrophic factor
CaM
calmodulin
CaMKII
calmodulin kinase II
ChAT
choline acetyltransferase
CREB
cAMP responding element binding
CHM
Chinese herbal medicine
clau
clausenamide
CL
clearance
Cmax
maximum concentration
CDK-5
cyclin-dependent kinase-5
DM
diabetes mellitus
DAG
diacylglycerol
ER
endoplasmic reticulum
ERK
extracellular signal-regulated kinases
GSK-3
glycogen synthase kinase-3
IP3
inositol triphosphate
LTP
long term potentiation
MWM
Morris water maze
NGF
nerve growth factor
NMDA
N-Methyl-D-aspartate
D
nNOS
neural nitric oxide synthase
PAT
passive avoidance tasks
Pir
piracetam
PLC
phospholipase C
PP1
phosphate 1
PKC
protein kinase C
tmax
time of peak concentration
t1/2α
absorption half-life
t1/2β
elimination half-life
Tau
microtubule-associated proteins
TCM
traditional Chinese medicine
Vd
apparent volume of distribution
VDCC
voltage-dependent calcium channel
©版权所有 ©2017 CSpace - Powered by
CSpace